Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Analgesic properties of a novel antagonistic anti-TrkA monoclonal antibody

Nov. 15, 2005

In vivo neuroprotective effects of NNZ-2566

Nov. 15, 2005

XIAP gene therapy for motor neuron diseases

Nov. 14, 2005

SSR-180575 ameliorates the neurodegenerative effects of FALS

Nov. 14, 2005

Femtomolar concentrations of DPI protect against inflammation and neurotoxicity in vitro

Nov. 14, 2005

ProEthic holds pre-IND meetings for fast-acting diclofenac products

Nov. 14, 2005

Cellegy amends European licensing agreement for Rectogesic with ProStrakan

Nov. 14, 2005

Pain Therapeutics and King sign agreement for Remoxy

Nov. 14, 2005

SELENBP1 identified as candidate gene for schizophrenia using novel approach

Nov. 11, 2005

Recent patents cover novel treatments for neurological disorders

Nov. 11, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...